References
- Sicherer SH. Epidemiology of food allergy. J Allergy Clin Immunol. 2011;127:594–602.
- Koletzko S, Niggemann B, Arato A, et al. Diagnostic approach and management of cow’s-milk protein allergy in infants and children: ESPGHAN GI Committee practical guidelines. J Pediatr Gastroenterol Nutr. 2012;55:221–229.
- Venter C, Arshad SH. Guideline fever: an overview of DRACMA, US NIAID and UK NICE guidelines. Curr Opin Allergy Clin Immunol. 2012;12:302–315.
- Berni Canani R, Nocerino R, Terrin G, et al. Effect of lactobacillus GG on tolerance acquisition in infants with cow’s milk allergy: a randomized trial. J Allergy Clin Immunol. 2012;129:580–582, 582.e581–585.
- Berni Canani R, Nocerino R, Terrin G, et al. Formula selection for management of children with cow’s milk allergy influences the rate of acquisition of tolerance: a prospective multicenter study. J Pediatr. 2013;163:771–777.e771.
- Guest JF, Panca M, Ovcinnikova O, et al. Relative cost-effectiveness of an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Italy. Clinicoecon Outcomes Res. 2015;7:325–336.
- Guest JF, Weidlich D, Mascunan Diaz JI, et al. Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Spain. Clinicoecon Outcomes Res. 2015;7:583–591.
- Guest JF, Weidlich D, Kaczmarski M, et al. Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Poland. CEOR. 2016;8:307–316.
- Guest JF, Kobayashi RH, Mehta V, et al. Cost-effectiveness of using an extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in the US. Curr Med Res Opin. 2018;34:1539–1548.
- Ovcinnikova O, Panca M, Guest JF. Cost-effectiveness of using an extensively hydrolyzed casein formula plus the probiotic Lactobacillus rhamnosus GG compared to an extensively hydrolyzed formula alone or an amino acid formula as first-line dietary management for cow’s milk allergy in the US. Clinicoecon Outcomes Res. 2015;7:145–152.
- Waserman S, Begin P, Watson W. IgE-mediated food allergy. Allergy Asthma Clin Immunol. 2018;14:55.
- Berni Canani R, Di Costanzo M, Bedogni G, et al. Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cow’s milk allergy: 3-year randomized controlled trial. J Allergy Clin Immunol. 2017;139:1906–1913.e1904.
- National Institute for Health and Care Excellence. Food allergy in under 19s: assessment and diagnosis [Internet]. 2011 [cited 2018 Nov 30]. Available from: https://www.nice.org.uk/guidance/cg116
- NHS Digital. National schedule of reference costs 2016–17 [Internet] [cited 2018 Nov 30]. Available from: https://improvement.nhs.uk/resources/reference-costs/
- Curtis LA, Burns A. Unit costs of health and social care 2017 [Internet] [cited 2018 Nov 30]. Available from: http://www.pssru.ac.uk
- National Institute for Health and Care Excellence. Guide to the methods of technology appraisal [Internet]. 2013 [cited 2018 Dec 24]. Available from: https://www.nice.org.uk/process/pmg9/resources/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781
- Skripak JM, Matsui EC, Mudd K, et al. The natural history of IgE-mediated cow’s milk allergy. J Allergy Clin Immunol. 2007;120:1172–1177.
- Wood RA, Sicherer SH, Vickery BP, et al. The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol. 2013;131:805–812.
- BSACI. Allergy in children [Internet] [cited 2018 Dec 24]. Available from: https://www.bsaci.org/resources/allergy-in-children
- Branum AM, Lukacs SL. Food allergy among children in the United States. Pediatrics. 2009;124:1549–1555.
- Cecil E, Bottle A, Sharland M, et al. Impact of UK primary care policy reforms on short-stay unplanned hospital admissions for children with primary care-sensitive conditions. Ann Fam Med. 2015;13:214–220.
- Wolfe I, Thompson M, Gill P, et al. Health services for children in western Europe. Lancet. 2013;381:1224–1234.
- Cecil E, Bottle A, Cowling TE, et al. Primary care access, emergency department visits, and unplanned short hospitalizations in the UK. Pediatrics. 2016;137:e20151492.
- Cecil E, Bottle A, Ma R, et al. Impact of preventive primary care on children’s unplanned hospital admissions: a population-based birth cohort study of UK children 2000–2013. BMC Med. 2018;16:151.
- NHS Digital. Hospital Admitted Patient Care Activity, 2016–17 [Internet] [cited 2018 Dec 24]. Available from: https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity/2016-17
- Asthma UK. Time to take action on asthma [Internet] [cited 2018 Dec 24]. Available from: https://www.asthma.org.uk/globalassets/campaigns/compare-your-care-2014.pdf
- Harrison MJ, Dusheiko M, Sutton M, et al. Effect of a national primary care pay for performance scheme on emergency hospital admissions for ambulatory care sensitive conditions: controlled longitudinal study. BMJ. 2014;349:g6423.